Mirae Fine Chemical Venture Capital
Hwaseong, KR ยท 1 known investors
MFC Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and key starting materials, and conducts R&D and mass production in pharmaceuticals and materials. Using high-purity crystallization technology, it develops and supplies Statin-class APIs such as TBFA and TPPBr, focusing on domestic production of imported pharmaceutical ingredients in South Korea.
Founders & leadership
ํฉ
ํฉ์ฑ๊ด
์
์๊ธฐํ
Investors ยท 1
Frequently asked questions
- What does Mirae Fine Chemical Venture Capital do?
- MFC Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and key starting materials, and conducts R&D and mass production in pharmaceuticals and materials. Using high-purity crystallization technology, it develops and supplies Statin-class APIs such as TBFA and TPPBr, focusing on domestic production of imported pharmaceutical ingredients in South Korea.
- Who are Mirae Fine Chemical Venture Capital's investors?
- Mirae Fine Chemical Venture Capital's investors include IMM Investment Japan.
- Where is Mirae Fine Chemical Venture Capital headquartered?
- Mirae Fine Chemical Venture Capital is headquartered in Hwaseong, KR.